Dyslexia Treatment Market Report 2025

This Dyslexia Treatment market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The dyslexia treatment market size has grown strongly in recent years. It will grow from $28.19 billion in 2024 to $30.26 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to global collaboration and sharing of best practices, shifting societal attitudes towards learning disabilities, adoption of comprehensive treatment plans that incorporate psychological, educational, and medical interventions, enhanced funding from government and private sectors for research and educational programs, implementation of laws and regulations mandating support for students with learning disabilities.

The dyslexia treatment market size is expected to see strong growth in the next few years. It will grow to $39.63 billion in 2029 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to growing awareness about dyslexia among parents, implementation of inclusive education policies and specialized educational programs for dyslexic students, an increase in the diagnosed cases of dyslexia, continuous training and development programs for educators and therapists, the rise of telehealth and online therapy services. Major trends in the forecast period include artificial intelligence tools for early diagnosis and customized treatment plans, the use of software-based interventions, the use of real-time brain activity monitoring to help individuals improve their reading skills, advanced speech-to-text applications to aid in reading and writing for dyslexic users, demand for devices that monitor cognitive functions and provide feedback to support learning and concentration.

The increasing prevalence of neurological disorders is expected to drive growth in the dyslexia treatment market in the coming years. Neurological disorders encompass a range of medical conditions affecting the nervous system, including the brain, spinal cord, and nerves. Factors contributing to the rising prevalence of these disorders include an aging population, changes in lifestyle, environmental factors, and improved diagnostic capabilities leading to better detection and reporting. Treatments for dyslexia, such as multisensory learning and cognitive training, hold promise for improving neurological conditions by enhancing brain plasticity and cognitive functions. According to the World Health Organization (WHO) in March 2024, more than 3 billion people globally were living with a neurological condition, with over 80% of related deaths and health losses occurring in low- and middle-income countries. Disparities in access to treatment are significant, with high-income countries having substantially more neurological professionals per capita compared to low- and middle-income countries. Therefore, the increasing prevalence of neurological disorders is a driving force behind the growth of the dyslexia treatment market.

Leading companies in the dyslexia treatment market are focusing on creating advanced solutions, such as the white noise feature, to better support customers. The white noise feature is an auditory tool that helps improve focus, concentration, and reading fluency, particularly for neurodivergent individuals, such as those with ADHD, by providing a consistent sound. For example, in October 2024, Promova Limited, a US-based technology company, introduced Dyslexia Mode 2.0, an enhanced feature aimed at making language learning more accessible for individuals with dyslexia and other neurodiverse conditions. Building on the original Dyslexia Mode, the new version includes enhancements such as adjustable font sizes, color shifting to reduce contrast, and the removal of all-caps text to improve readability. These updates are designed to reduce visual stress and offer a more comfortable learning experience for neurodivergent users. Developed with insights from experts like dyslexic designer Martin Pysny, Dyslexia Mode 2 aims to foster an inclusive, user-friendly environment that improves language learning for individuals with unique learning challenges.

In December 2022, Kyndryl Canada partnered with Dyslexia Canada to promote equitable access to education for students with dyslexia. This collaboration aims to raise awareness about the educational challenges faced by children and youth with dyslexia and to advocate for solutions that ensure fair and accessible education opportunities. Dyslexia Canada, a national charity based in Canada, is dedicated to improving the lives of children with dyslexia across the country.

Major companies operating in the dyslexia treatment market are Pfizer Inc., Astrazeneca Plc, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Purdue Pharma, Apotex Corporation, Endo International Plc, Amneal Pharmaceuticals LLC, Unither Pharmaceuticals LLC, RPG Life Sciences Ltd., Jubilant Pharma Limited, Breckenridge Pharmaceutical Inc., Rhodes Pharmaceuticals L.P., Cian Healthcare Pvt. Ltd, Lexia Learning Systems LLC, Wallace Pharmaceuticals Ltd., Ironshore Pharmaceuticals Inc., DK Pharmachem Pvt Ltd., Speechify Inc., Lingit AS, Lyfta, Nessy Learning Ltd.

North America was the largest region in the dyslexia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dyslexia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dyslexia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Treatment for dyslexia encompasses a variety of approaches and interventions aimed at enhancing the reading, writing, and spelling abilities of individuals with dyslexia. These typically involve specialized educational programs, including structured literacy and multisensory instruction, which utilize visual, auditory, and kinesthetic methods to support learning. Consistent practice, personalized assistance, and early intervention are crucial elements of effective dyslexia treatment.

There are several types of dyslexia treatment, such as double-deficit dyslexia, visual dyslexia, and phonological dyslexia. Double-deficit dyslexia involves challenges in both phonological processing (the ability to recognize the sound structure of words) and naming speed (the ability to quickly name letters and numbers). Therapy options for dyslexia include occupational therapy, speech therapy, and cognitive behavioral therapy, alongside medications such as cyclizine, meclizine, dimenhydrinate, methylphenidate, among others. These treatments are accessed through hospital pharmacies, retail pharmacies, and other distribution channels, catering to various end users such as psychiatric institutions, rehabilitation centers, and home care services.

The dyslexia treatment market research report is one of a series of new reports that provides dyslexia treatment market statistics, including dyslexia treatment industry global market size, regional shares, competitors with a dyslexia treatment market share, detailed dyslexia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dyslexia treatment industry. This dyslexia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dyslexia treatment market consists of revenues earned by entities by services such as literacy programs, multisensory interventions, assistive technologies, individualized education plans, cognitive training, and therapies targeting visual and auditory processing skills. The market value includes the value of related goods sold by the service provider or included within the service offering. The dyslexia treatment market also includes sales of assistive listening devices, phonological processing tools, digital pens and notetaking devices, eye-tracking devices, and multi-sensory learning tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.